Beacon Financial Advisory LLC Lowers Stock Holdings in Colgate-Palmolive (NYSE:CL)

Beacon Financial Advisory LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL) by 3.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 11,030 shares of the company’s stock after selling 415 shares during the quarter. Beacon Financial Advisory LLC’s holdings in Colgate-Palmolive were worth $1,145,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. E Fund Management Hong Kong Co. Ltd. purchased a new position in Colgate-Palmolive during the 2nd quarter valued at about $25,000. Continuum Advisory LLC raised its stake in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the third quarter worth $42,000. Gradient Investments LLC lifted its holdings in Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after buying an additional 400 shares during the period. Finally, Financial Connections Group Inc. purchased a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $68,000. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CL. Evercore ISI increased their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research report on Thursday, July 18th. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a report on Thursday, August 1st. Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Barclays lifted their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Finally, Jefferies Financial Group lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $103.00 to $95.00 in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Trading Up 0.7 %

CL opened at $94.26 on Wednesday. The business’s 50 day moving average price is $101.80 and its 200 day moving average price is $98.45. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a market capitalization of $77.01 billion, a PE ratio of 27.01, a P/E/G ratio of 3.33 and a beta of 0.42. Colgate-Palmolive has a one year low of $74.67 and a one year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.